John McBride

Insider Reports History

Entity
Individual
Location
C/O Tokai Pharmaceuticals, Inc., One Broadway, 14 Th Floor, Cambridge, MA
Signature
/s/ John McBride
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John McBride:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. Director Stock Option (right to buy) 150K May 1, 2023 Direct

Insider Reports Filed by John McBride

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELDN Eledon Pharmaceuticals, Inc. May 1, 2023 1 $0 4 May 2, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Director